Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Vitestro Logo
Vitestro Growth Score
92
CB Rank
8645
Heat Score
69
Vitestro transform patient care with autonomous blood drawing technology.
Founded
obfuscation
PrivateSeries B Utrecht, Utrecht, The Netherlands51-100 vitestro.com/
Health Care
Medical
Medical Device
Robotics
Overview

Vitestro
Total Funding
obfuscation
Growth Score
92
Heat Score
69

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score92
-1 pts
in past quarter
Heat Score 69
-22 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+3 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Vitestro

CB Rank
8645
Vitestro transform patient care with autonomous blood drawing technology.
Founded
obfuscation
PrivateSeries B Utrecht, Utrecht, The Netherlands51-100 vitestro.com/
Health Care
Medical
Medical Device
Robotics

Funding Rounds

Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Details

Legal Name Vitestro B.V.
Operating Status Active
Company Type For Profit
About the Company
Vitestro transform patient care with autonomous blood drawing technology.
Phone Number +31 30 2004551
Contact Email hello@vitestro.com
Predictions & Insights

Growth Insight

See this Growth Insight
Vitestro is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Aletta® Autonomous Robotic Phlebotomy Device™ (ARPD™)
An autonomous robotic device that performs fully automated venous blood draws using AI-driven ultrasound imaging and robotic needle insertion.

Research & Development

Vitestro is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Vitestro Logo
Series B - Vitestro
12
obfuscation
— Series B
obfuscation
Series B - Vitestro Logo
Series B - Vitestro
12
obfuscation
— Series B
obfuscation
Series B - Vitestro Logo
Series B - Vitestro
12
obfuscation
— Series B
obfuscation
Series B - Vitestro Logo
Series B - Vitestro
12
obfuscation
— Series B
obfuscation
Series B - Vitestro Logo
Series B - Vitestro
12
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Vitestro Logo
Series B - Vitestro
12
obfuscation
— Series B
obfuscation
Series B - Vitestro Logo
Series B - Vitestro
12
obfuscation
— Series B
obfuscation
Series B - Vitestro Logo
Series B - Vitestro
12
obfuscation
— Series B
obfuscation
Series B - Vitestro Logo
Series B - Vitestro
12
obfuscation
— Series B
obfuscation
Series B - Vitestro Logo
Series B - Vitestro
12
obfuscation
— Series B

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Contacts 19
News

News and Press

News•May 14, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 14, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

4,915
16.83%
 in past month

IT Spend

$403.6KThis year, Vitestro is projected to spend $403.6K on IT, according to Aberdeen.

Active Website Tech Count

39Vitestro is actively using 39 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

3Vitestro has registered 3 trademarks with the most popular class being 'Medical apparatus and instruments', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Vitestro's headquarters? Vitestro is located in Utrecht, Utrecht, The Netherlands.Who invested in Vitestro? Vitestro has 16 investors including LabCorp Venture Fund and  Puma Venture Capital.When was the last funding round for Vitestro? Vitestro closed its last funding round on
obfuscation
from a Series B round.Who are Vitestro's competitors? Alternatives and possible competitors to Vitestro may include Mobidiag, Neoteryx, and  Copan Group.How much funding has Vitestro raised to date? Vitestro has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(2e7868f 1)
|